Translate

Thursday, July 12, 2018

thumbnail

RGNX REGENXBIO Inc. gains 33% Jul 12, 2018

Developing gene therapies for rare diseases with a proprietary delivery platform.http://www.priceseries.com/trade/RGNX-REGENXBIO-Inc-stock-gains-33-percent-a-Trade-Record-by-priceSeries-2018061820180712.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive